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The structural basis of lipid interactions in lipovitellin, a soluble
lipoprotein
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Background:  The conformation and assembly of lipoproteins, proteins containing
large amounts of noncovalently bound lipid, is poorly understood. Lipoproteins
present an unusual challenge as they often contain varying loads of lipid and are
not readily crystallized. Lipovitellin is a large crystallizable oocyte protein of
approximately 1300 residues that contains about 16% w/w lipid. Lipovitellin
contains two large domains that appear to be conserved in both microsomal
triglyceride transfer protein and apolipoprotein B-100. To gain insight into the
conformation of a lipoprotein and the potential modes of binding of both neutral
and phospholipid, the crystal structure of lamprey lipovitellin has been determined.
Results:  We report here the refined crystal structure of lipovitellin at 2.8 Å
resolution. The structure contains 1129 amino acid residues located on five
peptide chains, one 40-atom phosphatidylcholine, and one 13-atom
hydrocarbon chain. The protein contains a funnel-shaped cavity formed primarily
by two β sheets and lined predominantly by hydrophobic residues. 
Conclusions:  Using the crystal structure as a template, a model for the bound
lipid is proposed. The lipid-binding cavity is formed primarily by a single-
thickness β-sheet structure which is stabilized by bound lipid. This cavity
appears to be flexible, allowing lipid to be loaded or unloaded.
Introduction
Soluble lipoproteins have a vital role in lipid transport and
metabolism. Because they usually contain varying amounts
of heterogeneous lipid, they are difficult to crystallize and
have not been amenable to X-ray diffraction studies. Lipo-
vitellin was the first lipoprotein to be crystallized with a
substantial portion of associated heterogeneous lipid [1]. As
the amino acid sequence of this protein was not known
at the time of the preliminary X-ray studies, the electron
density was interpreted in terms of an unrefined poly-
alanine model [2,3]. The subsequent determination of the
cDNA sequence [4] has permitted the assignment of the
amino acid sequence and refinement of the X-ray data.
Lipovitellin is the major lipid–protein complex found in
the yolk of egg-laying animals [5]. The protein can be
loaded with varying amounts of noncovalently bound lipid,
up to about 16% w/w lipid, two thirds of which is phospho-
lipid [6,7]. Lipovitellin is formed from the precursor, vitel-
logenin, which is the product of a single gene coding for
1659 to 1852 amino acids. Vitellogenin is synthesized in
the liver where it is loaded with lipid, phosphorylated and
glycosylated, and where it interacts with at least two Ca2+
ions and one Zn2+ ion [8].
After secretion of the vitellogenin dimer into the blood
stream and receptor-mediated endocytosis by oocytes,
vitellogenin undergoes specific and limited cleavage into
several polypeptide chains; the lipid-binding product is
now referred to as lipovitellin. The vertebrate lipovitellin
is comprised of a heavy chain (LV1) of approximately
120 kDa and a light chain (LV2) of about 30 kDa [5]. In
addition, the proteolytic processing of vertebrate vitello-
genin releases a smaller fragment, called phosvitin, which
ranges in molecular weight from 10 to 35 kDa, and which
remains loosely associated with lipovitellin. Phosvitin has
a high serine content, approaching 50% in some verte-
brates; most of these serine residues are phosphorylated
[5]. A detailed study of the proteolytic processing has not
been carried out and it is possible that in some species,
vitellogenin fragments are lost during this maturation
process. As the amino acid sequence of the lamprey form
was obtained from the vitellogenin cDNA, this post-trans-
lational proteolytic processing complicated the assignment
of the derived amino acid sequence to the X-ray diffrac-
tion data, as will be described below.
Raag et al. [2] obtained X-ray diffraction data to 2.8 Å from
crystals of lipovitellin purified from lamprey eggs and
derived a multiple isomorphic replacement electron-density
map. In the absence of an amino acid sequence, it was
only possible to build a preliminary polyalanine model of
984 residues into this initial map. The phases and electron
density were slightly improved by Poliks [3] who added an
additional 26 alanines. Because of weak or missing elec-
tron density, the chain tracing was interrupted at many
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points, mostly on the surface, and the initial model con-
sisted of about 30 separate segments. In addition, with the
exception of the helical domain, the polarity or direction
of the chain could not be determined.
The lipid contained in the complex is bound in a noncova-
lent manner and is extractable with organic solvents.
However, the lipovitellin used in this study, after precipi-
tation and lyophilization, remains in the native state with
bound lipid. Although chemical analysis indicated that the
soluble protein contains about 16% w/w lipid [1], no elec-
tron density could be assigned to lipid in the earlier work
of map interpretation and model building [2,3]. The iden-
tification of a large cavity bordered by two β sheets as the
major site of lipid binding was confirmed by low-resolu-
tion neutron diffraction with contrast variation [9]. 
In addition to its overall molecular organization, the
lipovitellin structure has broad physiological significance
because of its sequence homology with both apolipopro-
tein B-100 (apoB) and the lipid-carrying protein required
for very low density lipoprotein (VLDL) formation, micro-
somal triglyceride transfer protein (MTP) [10,11]. There is
a sequence of approximately 670 amino acids in the N-ter-
minal region of the lipovitellin segment LV1 which is
homologous to a similar-sized region in the N termini of
MTP [11,12] and apoB [10]. This homology is summa-
rized in Figure 1 and is marked in green.
The evolutionary relationship between lipovitellin, MTP
and apoB is further confirmed by the location of intron–
exon boundaries [12,13] and site-directed mutagenesis
studies (C Shoulders et al., unpublished data). In addition,
there is a cysteine-rich sequence of approximately 260
amino acids in the C-terminal region of lipovitellin (pink
in Figure 1) that has four complete copies and one
partially complete copy in pro-von Willebrand factor
(pro-vWF; Figure 1) [14].
In the results described below, the amino acid sequence
of lipovitellin derived from the cDNA has been placed in
the electron-density map and the resulting coordinates
have been refined. The resulting model still has disor-
dered regions where chain continuity is lacking. Nonethe-
less, it is now possible to describe details of the conforma-
tion that were not apparent with the initial polyalanine
model. On the basis of the earlier neutron diffraction
study and the shape of the cavity found in the crystal
structure, the nature of the amino acid sidechains that
form the lipid cavity surface can be described. An attempt
to analyze potential modes for the positioning of the lipid
components has also been carried out. The present model
structure contains 1129 amino acids refined to an R factor
of 0.19 at 2.8 Å resolution. 
Results and discussion
In order to use the cDNA sequence for interpreting the
electron-density map of lipovitellin [4], the cleavage sites in
the vitellogenin precursor had to be determined. Some
were obtained by N-terminal analyses of purified peptides;
others were estimated by counting residues based on mol-
ecular weights obtained with sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS–PAGE) results. The
primary sequence for the vitellogenin precursor and how it
relates to the X-ray study is given in Figure 2. The com-
plete sequence of lamprey vitellogenin can also be found in
GenBank with the accession code M88749.
Most lipovitellins contain a large and a small polypeptide
chain, the former being derived from the N-terminal end
of the precursor. In the lamprey system the larger molecu-
lar weight chain, LV1, is cleaved into two segments, here-
after referred to as LV1n and LV1c. Thus, the crystal
structure is formed from three separate polypeptide chains:
LV1n, LV1c and LV2. Figure 2 tabulates the regions where
amino acid structural assignments have been made in the
crystallographic model and is meant to aid in understanding
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Figure 1
Schematic representation of homology
regions among vitellogenin (VTG), microsomal
triglyceride transfer protein (MTP),
apolipoprotein B (apoB) and pro-von
Willebrand factor (pro-vWF). The homologous
regions found between vitellogenin, lipovitellin,
MTP and apoB are indicated in green. A small
region of vitellogenin near its C terminus is
homologous with a repeating domain in pro-
vWF and is shown in pink. The pro-vWF has
four full copies of the C-terminal region of
vitellogenin and one partial copy. The amino
acid numbering above the schematics
includes the leader sequence, shown in black,
of all of the proteins. The numbering
represents the first and last residues of the
homology regions. The chain length of each
protein is given at the C terminus.
17
22
28
34 386 745–784 865 1241 1947 2295 2813
703 4563
676 894
688 1566 1823
VTG
MTP
apoB
pro-vWF
Structure
the structural and chemical results. For example, although
the LV1n chain begins at Gln17 and ends at Tyr688 in
Figure 2, this segment actually encompasses more than
two structural domains. 
The largest of the lipovitellin protein components, LV1n,
has a Mr = 66,800 Da. LV1n resisted repeated attempts at
N-terminal sequencing using the Edman reaction, and the
N-terminal amino group was assumed to be blocked [4].
The X-ray structure suggested that the N terminus was a
pyroglutamic acid occurring at residue 17 in the vitello-
genin sequence (see Figure 2). A neural networks program
developed by Nielsen et al. [15] determined that the
leader peptide sequence of vitellogenin included only the
first 16 residues with Gln17 being the N terminus of
mature vitellogenin. The green underline in Figure 2 ends
at Tyr688 because this is the last residue to be fit into the
X-ray model from the LV1n chain.
Using Edman degradation, the N-terminal residue of
LV1c (Mr = 40,750 Da) was determined to be Arg708, the
beginning of the red underline in Figure 2. This means
that either 20 amino acids are disordered on the C-termi-
nal end of LV1n or are lost during the post-translational
proteolytic processing of vitellogenin. Furthermore, the
X-ray coordinates start again at Trp729, as shown in red
letters in Figure 2, so that 21 amino acids belonging to the
N-terminal region of LV1c are also disordered. Two more
disordered segments were found in LV1c. No electron
density could be found for the 19 residues in the region of
Met759 to Ala777, which would run across the large lipid
cavity opening. A second break begins at Met949 and
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Figure 2
Amino acid sequence of lamprey vitellogenin
and the crystal structure components. The
amino acid sequence of the lipovitellin
precursor, vitellogenin, is shown. Residues not
present in the X-ray model of lipovitellin are
colored a medium gray unless otherwise noted.
Residues are indicated as being present in one
of the three lipovitellin chains by colored lines
below the residue. In addition, a colored bar is
located to the left of the N-terminal residue of
each chain. As we lack experimental detail
definitively defining the C-terminal residues, the
presumed termini are not bound by lines. Chain
LV1n is indicated with green lines beginning
with Gln17, a pyroglutamate, and ending with
Tyr688. Chain LV1c is indicated with red lines,
beginning with Arg708 and with the assumed
ending at Pro1074. Chain LV2 is indicated with
blue lines beginning with Lys1306 and ending
at Lys1624, as described in the text. In contrast
to the underlining, the color of the one letter
amino acid code indicates its location in the
domain structure of LV as obtained from the
crystallographic analysis. Colors correspond to
the illustration in Figure 3b. Green characters
indicate the residues that form the N-sheet
domain, roughly Gln17 to Val296. Cyan-
colored characters mark those residues
forming the large α-helical domain, Thr297 to
Ser614. Red is used to denote the amino acids
forming the C-sheet domain, Lys615 to Tyr688
and Trp729 to Lys758. Dark blue letters mark
the residues forming the large A-sheet domain,
Gln778 to Lys948, Ser991 to Pro1074 and
Pro1358 to Phe1529. The three potential
N-glycosylation sites (Asn1097, Asn1298 and
Asn1675) are indicated with yellow boxes.
Between Ser1131 and Ser1284 there are five
polyserine regions (18, 12, 14, 8 and 23 amino
acids long) drawn in magenta; this region is
within the putative phosvitin region of lamprey
lipovitellin. (The figure was prepared using the
program ALSCRIPT [52].)
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continues for 42 residues to Phe990; this is one of the gray
lettered segments underlined in red (Figure 2).
The third chemically identified polypeptide chain, LV2,
stains as a phosphoprotein in SDS–PAGE experiments
[1], and has an N-terminal amino acid sequence begin-
ning with Lys1306 (Figure 2): KYVPQRKPQTSRRHT-
PASSSSSSSSSSSSSSSSSSSDSDMTVSAESFEKHSK1357.
This segment is not visible in the electron-density map,
and most of its serine and threonine residues are thought
to be phosphorylated. Although not detected within the
lamprey lipovitellin complex, the 231 residues from the
end of LV1c to the beginning of LV2 represent the
phosvitin region of the lamprey vitellogenin. This puta-
tive phosvitin contains 94 serine and seven threonine
residues; approximately half of these residues appear to be
phosphorylated as shown by 31P NMR experiments [1]. 
In summary, of the 1823 amino acids present in lamprey
vitellogenin, the lipovitellin model contains 672 residues
in LV1n, 285 in LV1c and 172 in LV2. The crystal struc-
ture includes several breaks so that there are a total of five
peptide chains, one 40-atom phosphatidylcholine, one 13-
carbon hydrophobic chain, and 59 water molecules. Clearly,
there are residues missing in the electron-density for
LV1c and LV2. Interestingly, the 672 residues found by
X-ray crystallography for LV1n gives a molecular weight
of about 74,000, which is considerably greater than the
66,800 Da determined by SDS–PAGE.
Domain organization of lipovitellin
The crystal structure can be divided into the three poly-
peptide components mentioned above or into a series of
domains which conform more closely to the three-dimen-
sional organization. The latter is clearly more useful in
describing the crystallographic model. Both the polypep-
tide components and the general shape and domain struc-
ture of a single subunit are shown in Figures 3a and 3b.
The domain structure and the large cavity are shown in
Figure 3b. In this representation of the crystal structure,
there are three predominantly antiparallel β-sheet domains,
referred to as the N sheet, A sheet and C sheet, and a large
helical domain. The 12 strands of the N sheet domain are
formed from LV1n and include residues 17–296. Excep-
tions are the two β strands located within a long loop
(residues 186–207). The main sheet structure is only one
β strand short of closing off to form a barrel-like domain.
The connection between the domain structure and the
proteolytic processing of the precursor is obscure. It is
possible, however, to speculate about the location of the
missing segments. Both the long phosvitin region between
LV1c and LV2 and the shorter connection between LV1n
and LV1c may be parts of the polypeptide chain which
loop out from the core lipovitellin dimer into the
adjacent solvent. LV1n is the longest piece of the
primary structure and contains two domains, the N sheet
and helical domain. In addition, five of the seven strands
of the C sheet are from LV1n. Contacts between either
the N sheet or the helical domain and the lipid cavity are
limited. As will be described later, the lipid cavity is
formed primarily from segments derived from LV1c and
LV2, which comprise all of the A sheet and about a third
of the C sheet (see Figure 3b).
The overall model properties of the domains, as observed
in the crystal structure, are described in Table 1. The
A-sheet and C-sheet domains form the bulk of the lipid-
binding cavity and generally are characterized by the
weakest electron-density. To some degree, this can be
seen by the B factors observed in the A and C sheets
which are generally higher than those of the N sheet and
the helical domain.
Although the A and C sheets form most of the lining of
the lipid-binding cavity and must have extensive contacts
with the bound lipids, they have little contact with each
other. This is apparent in Figure 3b. The contact areas
were calculated: N sheet to helical domain, 2400 Å2;
N sheet to A sheet, 6400 Å2; N sheet to C sheet, 2300 Å2;
helical domain to A sheet, 5000 Å2; helical domain to
C sheet, 4600 Å2; and A sheet to C sheet, 900 Å2. The
major stabilizing domain of the entire complex is the
helical domain. It has a large buried surface area relative to
the A and C sheets.
The smaller, seven-stranded sheet (the C sheet) is formed
from LV1n (residues 196–197 and 615–688) and LV1c
(residues 729–758). It has been so labeled because it
makes many contacts with the C terminus of the helical
domain. A proteolytic cleavage site must occur between
residues 688 and 708, and more likely between 700 and
708. The 700–708 segment is suspected because it is part
of a peptide insertion which is not found in the other ver-
tebrate vitellogenins; LV1 in most species is not cleaved
into two fragments.
The larger β sheet is composed of 23 β strands formed pri-
marily from LV1c (residues 778–948 and 991–1074) and
LV2 (residues 1358–1529) with one strand coming from
LV1n (residues 188–190). It has been referred to as the
A sheet because it has interactions with the amino termi-
nus of the helical domain. As noted above, this domain
forms most of the molecular surface for the lipid cavity.
When compared to other lipovitellin family members, this
domain contains the smallest number of conserved residues
(16%), probably because it has the fewest protein–protein
contacts and the most sidechain contacts with lipid. The
extent of conservation in the other domains, as deter-
mined by multiple sequence alignment, ranges from 25 to
31%. The N sheet and helical domains that have the most
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protein–protein contacts are the most highly conserved —
31% and 30%, respectively.
There are four regions of the vitellogenin sequence which
are chemically known to be present in the complex, and
which we were unable to build into the electron-density:
Arg708–Asp728, Met759–Ala777, Met949–Phe990 and Lys1306–
Lys1357. Eight of the residues in Arg708–Asp728 are due to
the insertion responsible for the cleavage of LV1 into two
chains. Met759–Ala777 chemically links the C sheet to the
A sheet; this 19 amino acid chain stretches across the large
opening of the lipid cavity and presumably is surrounded
on all sides by phospholipid headgroups. Met949–Phe990
is very polar, including 12 glutamines and five histidines.
The location of this gap (see Figure 3a) suggest that this
very polar segment projects into the solvent region, forming
a partially disordered minidomain. Part of this missing
segment may interact with the posterior surface of the
lipid cavity as shown in Figure 3a. As mentioned previ-
ously, Lys1306–Lys1357 contains a large number of serines
believed to be phosphorylated, and this rather large
segment would extend from the middle of the A sheet in
an unknown conformation.
On the basis of lipid and 31P NMR analyses, the number
of phosphorylated serine and threonine residues per
monomer was estimated at 55 [1,16]. No electron density
was found to be consistent with a phosphoserine or phos-
phothreonine residue. In particular, we were unable to
find any density for the polyserine segment including
residues 1323–1341. This segment must be disordered
and located in the surrounding milieu. It is also possible
that a small phosvitin chain is missing in the X-ray model.
This would consist of a subfragment between Ser1131 and
Phe1305. This segment is 231 residues long and contains
94 serine residues believed to be phosphorylated. A
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Figure 3
Stereoview ribbon diagrams of the lamprey
lipovitellin monomer. (a) The view looking
down into the funnel-shaped cavity with the
widened anterior. The cartoon is color-coded
to show the amino acid sequence
organization in the crystal structure. Residues
belonging to LV1n (Gln17 to Tyr688) are
shown in green, residues belonging to LV1c
(Trp729 to Lys758, Gln778 to Lys948 and
Ser991 to Pro1074) are in red, and LV2
residues (Pro1358 to Phe1529) are in dark
blue. The lipid ligands, L1 and L2, are drawn
in orange, with the phosphate atom of L1
shown as a sphere in purple. The N and C
termini of each chain are labeled with a
residue number, as are all cysteine residues
forming disulfide bonds. In addition,
approximately every twentieth residue is
labeled. Bonds have been drawn in yellow
along the Cα-S-S-Cα atom positions for the
five disulfide bonds (Cys156–Cys182,
Cys198–Cys201, Cys443–Cys449,
Cys1014–Cys1025 and Cys1408–Cys1429).
It was impossible to have them all appear
readily visible and the reader may find it useful
to also observe them in Figure 7. (b) The
colors on the protein ribbon have been
changed to illustrate the domain organization
of the monomer. The structural domains are
color-coded: the N-sheet domain is shown in
green, the helical domain in cyan, the C-sheet
domain in red, and the A-sheet domain in dark
blue. (The figures were prepared using the
program SETOR [53].)
polypeptide chain of this composition probably would not
stain with Coomassie blue on SDS–PAGE gels.
Helical domain
The helical domain in lipovitellin is an unusual form of
supersecondary structure not commonly found in a globular
protein. It consists of a coil of α helices which forms a clamp
linking together the two β sheets that form the walls of the
lipid-binding cavity [2,9]. Viewed from the edge, the helical
domain has a crescent shape and consists of two layers, one
toward the center of the molecule, the other on the surface.
Only about 30 sidechains of this domain interact directly
with the cavity. The helical domain is found in LV1n,
residues 297–614, as shown in Figure 3. 
The long loop from 498 to 505 connecting helices 12 and
13 is in a region of poor electron-density, resulting in a bad
torsional angle at Gln499. 
Arrangement of all the helices (with the exception of
helix 8) in a right-handed supercoil results in a roughly
parallel grouping of helices within each layer and an
antiparallel grouping between layers. Much like helical
domains in other proteins, the interhelical axes are canted
slightly away from 0°, corresponding to parallel, and
180°, indicating antiparallel. The angular relationship
between helical axes was determined using Promotif [17].
For helices in the same plane, the interhelical angles
range from 15° to –66°; for interactions between planes,
the angles range from 118° to 164°. In addition to the 17
α helices of the supercoil, one short α helix, helix 8, is
present in a loop connecting the longer helical segments
(helices 7 and 9 in Figure 4).
The two layers of the helical domain lead to three side-
chain surfaces: an outer layer, an inner layer and a central
portion containing the interface between the two layers.
The outer layer faces the solvent with the exception of
helices 14, 16 and 18 which make contact with the other
monomer. Clearly less hydrophobic than the inner face,
the outer layer contains nearly all polar and most of the
ionizable sidechains in the helical domain. One of the
most interesting features of the helical domain is exem-
plified by the amino acid types in the interface layer,
which are largely hydrophobic. The nonpolar character of
the middle surface suggests that this domain has a core
resembling most other globular proteins. One would
predict that the helical domain would form a stable glob-
ular polypeptide in the absence of the rest of the
lipovitellin structure. Of the 59 water molecules found in
the crystal structure, 25 are hydrogen bonded to
sidechains in this domain.
There is one disulfide bridge connecting the end of helix
9 to a loop right before the start of helix 10 (see
Figure 4). There are also four partially buried salt bridges
between neighboring helices each involving two hydro-
gen bonds between the electrostatically paired side-
chains (Arg358–Glu390, Lys478–Glu513, Arg519–Glu556
and Arg547–Glu574). These bridges are labeled as α, β, γ
and δ, respectively, in Figure 4. The first three bridges
restrain helices on the inner surface of the helical domain:
helices 4 to 6, helices 11 to 13 and helices 13 to 15. The
fourth salt bridge occurs between helix 15 of the inner
surface and helix 16 on the solvent-accessible surface.
Nearly a third of the helical domain residues are strictly con-
served in six of the seven vertebrate vitellogenins that were
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Figure 4
Cartoon representation of the helical domain of lipovitellin. This
enlarged view shows the layered nature of the helical domain. The
position of the Cys443–Cys449 disulfide bond is marked in yellow.
The four partially or fully buried salt bridges in the helical domain are
labeled: (α) Arg358–Glu390, (β) Lys478–Glu513, (γ)
Arg519–Glu556 and (δ) Arg547–Glu574. Their respective sidechains
are colored with anionic residues in red and cationic residues in blue.
(The figure was prepared using the program SETOR [53].)
Table 1
Temperature (B) factors for the domains in crystalline
lipovitellin.
No. of No. of
mainchain Average sidechain Average
atoms B factor atoms B factor
N sheet 1120 53 1084 55
Helical domain 1272 50 1238 55
C sheet 418 67 393 72
A sheet 1711 77 1582 81
PLC 40 43
C13 13 45
Waters 59 38
compared. Among the conserved residues is a strikingly high
number of conserved leucine (16) and valine residues (5).
The arrangement of leucine, valine and isoleucine residues
is somewhat similar to that found in the leucine zipper
motif. Instead of two α helices, however, the hydrophobic
sidechains intercalate from four neighboring helices.
A search for an internal consensus sequence for this super-
secondary structure met with little success. The helical
domain has 12 proline residues; nine are conserved within
the lipovitellin family. Of the prolines found in the helical
domain of lamprey lipovitellin, six are at the beginning of
α helices (Pro326, Pro425, Pro450, Pro486, Pro526 and
Pro596), three are in turns (Pro497, Pro575 and Pro559),
and three are in the middle of a helix (Pro366, Pro456 and
Pro535). Although it is possible that these proline residues
impose conformational restrictions favoring the parallel
structure, it is likely that the packing of the α helices is
influenced more by the locations of the hydrophobic
residues mentioned above.
The helical domain of lipovitellin was the first-discovered
superhelical right-handed, coil-coiled structure with a two-
helix repeat unit [2]. A similar supersecondary structure was
subsequently found in two domains of soluble lytic transg-
lycosylase (SLT) from Escherichia coli [18]. In SLT, the
N-terminal domain contains 22 α helices in 360 amino acids
packed in a U-shaped conformation. In combination with a
second smaller domain containing four α helices, a torus is
formed with a large central hole 25–35 Å in diameter. The
helical domain in lipovitellin and SLT leads to a series of
parallel helix–helix interactions that are in marked contrast
to the all antiparallel helical contacts found in typical
helical-bundle proteins, such as apolipoprotein E receptor-
binding domain or apolipophorin III [19,20].
N-sheet domain 
Consisting of residues 17–296 of LV1n, this domain con-
tains the putative N-terminal pyroglutamate (pyrrolidone
carboxylic acid) identified by the placement of the amino
acid sequence in the electron-density map. The presence of
the modified N terminus suggests that the first 16 amino
acids comprise the endoplasmic reticulum (ER) signal
sequence and are removed during translocation of vitello-
genin into the ER. A glutamine sidechain at the N terminus
will spontaneously cyclize, eliminating ammonia to form
pyroglutamate. As can be seen in Figures 3b and 5, the
N-sheet domain resembles the compact structure of a
typical globular protein. It contains 4 α helices and 12
β strands, 11 of which form a barrel-like conformation. The
barrel has a gap between two strands which prevents forma-
tion of a continuous surface by the β structure. Of the four
α-helical segments, two are only four residues long.
The electron-density for this portion of crystalline lipo-
vitellin was generally good. Atoms in the N-sheet domain
have comparatively low temperature factors (Table 1) and
good geometry with the exception of the type IV β turn
from 165–168 (in Figures 3a and 3b, this turn is behind
residue 220). This segment forms crystal contacts between
the lipovitellin dimers and is within a few ångströms of a
crystallographic twofold rotation axis. In addition, the
program Errat [21] indicated that the β-strand region from
43–48 was found in less then 2% of its library of structures
even though the electron-density for this region is very
good. Finally, 20 of the 59 water molecules found in the
crystal structure form hydrogen-bonding contacts with
residues from this domain.
A 14-residue α helix is in the center of the shell formed by
the N sheet. It consists of mainly uncharged residues and
has the amino acid sequence T120DTAVNIVRGILLFQ.
The single ionizable sidechain (Arg128) extends to the
aqueous surface while most of the other helical sidechains
are buried. The domain also contains two disulfide bridges
found in the LV1n chain linking Cys156 to Cys182 and
Cys198 to Cys201. The 156–182 disulfide bridge appears
to be conserved in both MTP and apoB. An extended con-
nection from 185–208 forms two short β strands, one inter-
acting with the C sheet and the other with the A sheet
through typical β strand–β strand hydrogen bonds.
The combination of the 185–208 segment and a depres-
sion in the surface of the N sheet leads to an unusual
crevice or pit that accommodates the ends of several of
the long β strands that form the walls of the lipid-binding
cavity. The strands belong to the A sheet and are curved
to conform to the direction of the strands in the N sheet.
Strand–strand hydrogen bonding occurs and a short
segment of β sheet forms from segments of polypeptide
chain that are long distances apart in the primary struc-
ture. These interactions have the appearance of a ball-
and-socket junction which appears to have the potential
to be flexible. This junction could have an inherent
function in the loading of lipid to the folded or partially
folded polypeptide chain.
The A and C sheets and the lipid-binding cavity
Lamprey lipovitellin, as noted previously, must contain
anywhere from 25–40 molecules of lipid (mostly phospho-
lipid) per subunit. Using 31P NMR, it has been suggested
that the phospholipid is present in the form of a condensed
state such as a monolayer or bilayer [16]. The precise
number of bound lipid molecules is not easily determined
and indeed may vary somewhat from molecule to mol-
ecule. Experimental evidence for lipid domain variations
comes from the observation that additional spin-labeled
fatty acids can be taken up by lipovitellin when it is in the
solution state [22]. Either the protein is very rigid, and
water and other molecules are exchanged to accommodate
these spin probes, or the cavity can expand somewhat to
accommodate additional lipid molecules.
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Earlier crystallographic models of lipovitellin indicated a
large cavity in each of the subunits of the dimer. Because
of weak electron-density around the binding cavity, partic-
ularly at the solvent-accessible turns connecting the
antiparallel β strands, it was the most difficult region to
interpret. In fact, as shown in Figure 2, several segments
of LV1c and LV2 are still missing in the map and X-ray
model. Neutron-scattering studies with contrast variation
provided strong evidence that the cavities contained the
bound lipid [9]. Once it was demonstrated that the cavity
contained the lipid, the X-ray crystallographic results
showed that there must be two noncontiguous lipid-
binding domains present in the dimer.
The lipid-binding cavity, as visible in Figures 3a and 3b, is
formed primarily by the A and C sheets and a small
section of the helical domain. It is roughly funnel- or cup-
shaped and is accessible to solvent at both ends. Viewing
the monomer (Figures 3 and 5), a third breach in the
protein surface appears, which is closed off by dimeriza-
tion (Figure 6). The two β-sheet domains consist of mainly
antiparallel strands. Residues 778–948 represent the first
contiguous segment of the A sheet. This first segment has
two bends in most of the strands leading to a ‘Z’ appear-
ance when the sheet is viewed edge-on. The topmost part
of the Z fits into the pit in the N domain and forms the
ball-and-socket arrangement referred to earlier.
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Figure 6
Stereoview ribbon diagram of the lipovitellin
homodimer. The crystalline lipovitellin dimer is
depicted in cartoon representation. Each
monomer is color-coded as in Figure 3b:
N sheet green, helical domain cyan, C sheet
red, A sheet dark blue, disulfide bonds yellow,
lipids (L1 and L2) orange, and the phosphate
of L1 purple. Two black lines above and
below the homodimer mark the position of the
dimer dyad. Most of the A sheet is
unsupported by monomer–monomer contacts.
(The figure was prepared using the program
SETOR [53].)
Figure 5
Stereoview ball-and-stick representation of
the lipovitellin monomer showing the polarity
of its sidechains. The backbone atoms (N, Cα,
C and O) are all colored light gray.
Hydrophobic sidechains (alanine, valine,
leucine, isoleucine, methionine, phenylalanine
and proline) are colored green, anionic
sidechains (glutamate and aspartate) are
colored red and cationic sidechains (lysine,
arginine and histidine) are colored blue; all
other residues are colored yellow. The
preponderance of hydrophobic residues along
the inner surface of the lipid cavity is
apparent. In addition, there are rings of basic
residues occurring at positions that could
interact with the phosphate moiety of the
bound phospholipids. (The figure was
prepared using the program SETOR [53].)
Two other unusual bends lead to the appearance of a
bulge on the otherwise relatively smooth sheet. The
β strand appears to be distorted beginning at residues
915 and 1056 with the amino acid sequences P915FQQKT
and P1056TSSKA, respectively. The distortion appears to
accommodate a change in orientation of the sheet
belonging to LV2 (dark blue segment in Figure 3a). As
noted in the section describing the amino acid sequence,
residues from 1306–1358 are missing. Half of the
residues in this segment are serines that are believed to
be phosphorylated. 
The polarity of the sidechains that line the cavity is
visible in Figure 5. The sidechains pointing inward
towards the cavity are predominantly hydrophobic with
the additional presence of a few neutral polar groups from
threonine, serine, asparagine, glutamine, tryptophan, cys-
teine or tyrosine residues. The hydrophobic residues are
relatively uniformly distributed over the cavity surface.
Around the larger opening to the cavity is a ring of basic
and polar sidechains including Lys757, Lys758, Lys787,
Lys1359, Tyr1382, Thr392, Ser388, Gln1071, Asn1387
and Thr1440. In the hypothetical initial positioning of
phospholipid molecules described below, we considered
these sidechains to be of significance. In this modeling,
the hydrophobic lipid fills the cavity; the charged hydro-
philic phospholipid headgroups form the aqueous inter-
face at the mouth of the funnel and interact with the ring
of basic and polar sidechains.
Ordered lipid molecules 
There were two regions of electron-density in the final
map which could not be interpreted by the polypeptide
chain. One region was accurately modeled by a phos-
phatidylcholine with carbon chains of length 16 and 6,
labeled L1 in Figures 3a and 3b. The other region resem-
bled an extended 13-atom hydrocarbon chain, and is
labeled L2 in Figures 3a and 3b. Both of these com-
pounds must be bound with sufficient affinity to be
ordered but still may have disordered segments. We
believe they are lipid molecules and are in a different
state than most of the lipid bound by lipovitellin. The
electron-density for both L1 and L2 was strong (3–5σ)
and both structures refined with relatively low tempera-
ture factors as given in Table 1. 
Both L1 and L2 are located near the juncture of the N and
the A sheets. The interaction between these two domains
forms the ball-and-socket relationship described earlier.
The phosphatidylcholine, L1, binds in a large loop formed
by residues 185–206 at the narrow end of the lipid
‘funnel’. This loop region of the N sheet is stabilized on
both ends by disulfide bridges linking Cys156 to Cys182
and Cys198 to Cys201. Loop 185–206 is the nexus of the
structure, interacting with residues in the helical domain,
the A and C sheets, and L1.
At the L1 site, three sidechains, Tyr187, Thr189 and
Thr192, belonging to the N sheet, form hydrogen bonds
with the phosphate of the headgroup. None of these
residues is conserved in the other vertebrate vitellogenins.
Van der Waals contacts are made between the hydro-
carbon chain and residues of the A sheet, Val805, Tyr807
and Ala871, and the C sheet, Tyr669. Only Val805 and
Ala871 are strongly conserved.
The second lipid-binding site, L2, is difficult to describe
in any detail. It could be anything from a segment of a
phospholipid to a triglyceride. The only crystallographi-
cally ordered fragment was modeled as a C13 hydrocarbon
chain. It appears in a region that is relatively distant from
the lipid cavity and has no direct connection to the lipid
funnel. L2 is located in a nonpolar region of the protein
and has hydrophobic interactions with residues from the
N sheet: Ala30, Leu71, Phe93, Thr122 and Ile126. The
other part of the binding site derives from the A sheet and
includes sidechains from Ile813, Ile815, Thr877 and
Leu879. The two isoleucines form an antiparallel turn
having the sequence Ile-Gly-Ile. In the other vertebrate
vitellogenins, three of these residues, Thr122, Ile126 and
Thr877, are strongly conserved and the fourth position,
Leu879, is always hydrophobic.
Zn2+ site?
Both calcium and zinc ions have been found bound to
lipovitellins and probably have an important role in differ-
entiation and development of the oocyte. Recent EXAFS
studies indicated the presence of at least one Zn2+ per
monomer in most lipovitellins. This data suggested that
the Zn2+ ion was liganded to two histidine residues [23].
Montorzi et al. [8] speculated that Zn2+ would not be
found in our lipovitellin crystal structure because of the
presence of 1 mM EDTA in the buffer used for crystal-
lization. This appears to be the case as we were unable to
find any evidence of Zn2+ density. 
In spite of the absence of any sign of metal ions in the elec-
tron-density map, the crystallographic model was examined
for possible metal-binding sites. Of the 23 histidines present
in the model, only two regions have histidine pairs that
could possibly form the Zn2+ binding site. They are His312
and His322 in the helical domain, and His868 and His887 in
the A sheet. The two sites are only 12 Å apart. The His312/
His322 site is more highly conserved and is found in the
chicken, toad, trout, lamprey, and one of the killifish
sequences. The immediate environment around this site
contains several additional residues which could interact
with Zn2+: Asn316, Asp324 and Lys328. The His868/His887
site is less conserved. Although His868 is found in all but
one of the killifish sequences, His887 is conserved only in
lipovitellin from lamprey, toad and sturgeon. The prediction
that a Zn2+ site is present and involves His312/His322 may
be important to embryogenesis. 
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Interdomain and subunit–subunit interactions
Because of the unusual framework of the lipoprotein,
added significance must be given to interdomain interac-
tions. Although ten of the 14 cysteine residues present in a
lipovitellin subunit form disulfide bonds, none of these is
an interdomain connection. Instead, there is a large
number of conserved salt bridges involved in important
interdomain interactions. They are characterized by dual
hydrogen-bond separations between polar atoms of basic
and acidic sidechains. For example, four of the 12 con-
served and partially buried salt bridges form in the inter-
face between the helical domain and the C sheet. There is
also a conserved ionic bridge between the helical domain
and the A sheet (Arg337 to Glu804). 
In contrast, the contacts between the N-sheet domain and
A sheet are more nonpolar in character. The hydrophobic
residues of the ω-turn connecting strands 2 and 3 inserts
into a cleft present in the N sheet, just to the right of L2
in Figures 3a and 3b. In addition, the loops connecting
strands 4 and 5, 6 and 7, and 8 and 9 of the A sheet all have
sharp, nearly 90° bends, which present residues involved
in hydrophobic interactions with the N sheet. 
As both lipovitellin and vitellogenin are dimers in solu-
tion, the subunit–subunit interface is important to the
overall structure. The early X-ray studies demonstrated
that the molecule has C2 symmetry and in the crystals the
dyad is congruent with a crystallographic twofold rotation
axis. Figure 6 shows one view of the dimer which has the
appearance of an ‘X’. A single subunit runs along each of
the diagonals. It has been color coded to highlight the
arrangement of the main cavity-forming domains — the
N sheet and the helical domain. The latter two domains
form the principal contact surfaces between subunits.
Close to the molecular dyad, the A sheet also makes
subunit–subunit contacts. 
There are strong monomer–monomer contacts that stabi-
lize the noncavity regions and which support the regions
of the cavity sheets where they attach to the compact
protein region (Table 2). Of the area of the dimer contact,
41% is between the two A sheets. The remainder is
between the N sheet of one subunit and the helical
domain of the other. This suggests that both the N sheet
and helical domains have an important role in organizing
and supporting the cavity forming A and C sheets, and
that dimerization plays an integral role in establishing the
functional lipid-binding structure. 
Hypothetical phospholipid binding in the cavity
The total absence of electron-density for any lipid mol-
ecules in the binding cavity leaves a major unanswered
question regarding the orientation and protein interactions
of the bound lipid. On the basis of the 31P NMR results,
the phospholipid should be present as either a monolayer
or bilayer [16]. The disorder in the crystal structure sug-
gests that multiple conformations are likely but this would
still be in agreement with the NMR results. 
By taking into account the presence of nonpolar residues
lining the cavity and the ring of basic and polar residues
identified and mentioned above, possible orientations for
a phospholipid microdomain were tested. Only a mono-
layer was considered in detail as the funnel shape of the
cavity would otherwise necessitate modeling layers with
different numbers of phospholipid on the two sides and
would not provide for an adequate volume of neutral lipid.
The monolayer shown in Figure 7 was constructed by
manually positioning the dipalmitoyl phosphatidyl choline
(DPPC) molecules along the edges of the mouth of the
cavity, being careful to place phosphate groups close to
the positively charged sidechains present at the outer ring
of the cavity. A total of 38 molecules of DPPC were added
to the crystallographic coordinates of the protein.
Several rounds of conjugate gradient energy minimization
using X-PLOR followed by manual rebuilding were
carried out. During these calculations, the protein coordi-
nates were fixed and the electrostatic terms turned off.
The structure of the DPPC monolayer as shown in
Figure 7 satisfies simple steric considerations. Moreover,
the energy dropped from 5.5 × 109 to –760 (kcal mol–1, rel-
ative scale). Because of the initial placement of DPPC
molecules interacting with the ring of basic residues, the
hydrocarbon chains of one DPPC molecule ended up
nearly perpendicular to another across the opening. As an
increasing number of DPPC molecules were added, a
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Table 2
Table of polar interactions between monomers in lamprey
lipovitellin.
Monomer 1 Monomer 2 Distance (Å)
E38 OE1 R1506 NH1 3.13
E38 OE2 R1506 NH2 2.80
E233 OE1 R572 NH1 3.34
R635 NH1 E1482 OE1 2.94
K1043 NZ E1482 OE2 3.10
T176 OG1 A562 O 2.89
N215 OD1 R570 NE 2.75
E233 OE1 R572 NH1 3.34
K244 NZ S591 O 3.24
K244 NZ S593 O 3.23
Q997 OE1 K1489 NZ 3.26
I1001 O N1508 ND2 2.96
bulge was necessary in the monolayer near the center.
The net effect was the visible dome-shaped curvature on
the surface of the monolayer.
With the phospholipid microdomain present in the crystal
structure of the protein, the lipovitellin molecule had a
smoother overall surface. When examined closely, the
hydrocarbon chains of the microdomain have neighbors
with similar orientations. This puts each phospholipid
molecule in an anisotropic environment. Therefore, in
localized segments, the DPPC orientations resemble that
found in a monolayer. Over the entire microdomain and
because of the curvature, however, the domain also has a
crude micellar appearance. The current model is thus a
hybrid between a microdomain of a single-layered lipo-
some and a micelle. The inner surface of the phospholipid
microdomain consists of the hydrocarbon tails of the phos-
pholipids and therefore is completely nonpolar.
To complete the description of the lipid cavity shown in
Figure 7, several additional points are noteworthy. A
nearby segment consisting of residues 759–777 is disor-
dered, and could be responsible for reducing part of the
headgroup surface area in the present model. In addition,
a relatively large cavity still remains near the inner
concave surface formed by the hydrocarbon tails of the
phospholipid. This could function to accommodate the
neutral lipid (4.5% w/w) known to be present. No attempt
has been made to model the neutral lipid, but the site is
marked in Figure 7 by the bile pigment biliverdin (pink
porphyrin ring) which is known to be present at a
stoichiometry approaching one per dimer [24]. This same
internal cavity could be the location of other neutral lipids
such as triglycerides. 
Implications of lipovitellin structure for MTP and apoB
As discussed above, the 672 N-terminal residues of
lipovitellin are homologous to the N-terminal regions of the
lipoproteins MTP and apoB. MTP is an intracellular
protein involved in the transfer of lipid to apoB in the first
stage of VLDL formation. ApoB is the major protein con-
stituent of VLDL and low density lipoprotein (LDL). As all
three of these proteins are involved in lipid transport, the
amino acid sequence homology can be used to make some
predictions about structures. In terms of evolutionary analy-
sis, the sequence relationships suggest that vitellogenins
evolved first, and that MTP and apoB arose by divergent
evolution [25]. Consistent with this analysis, a BLAST [26]
search of the Caenorhabditis elegans genome yielded several
copies of vitellogenin, but no MTP or apoB [27].
In terms of the crystal structure of lipovitellin, the amino
acid sequence similarities predict that all of the N sheet,
the helical domain and most of the C-sheet region are
present in the homologous family. Only the A sheet which
forms the bulk of the extended lipid-binding cavity (see
Figures 3b and 6), contains no significant similarity to the
amino acid sequences of the other family members. As the
A sheet in lipovitellin consists of 450 residues and only
about 200 residues are available to form a similar domain
in MTP, this cavity-forming region must either be signifi-
cantly truncated, or it must involve an altogether different
conformation. The former hypothesis is consistent with
the much smaller lipid:protein monomer ratio of about 3
in MTP [28,29] versus 38 or more in lipovitellin [1]. 
The 676 residues which are homologous to lipovitellin
represent only about 15% of the polypeptide chain of
apoB. Predictions about the structure of the LDLs based
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Figure 7
Stereoview of the lipovitellin monomer
perpendicular to a modeled DPPC monolayer.
The crystal structure shown includes bound
phospholipid modeled as described in the
text. Each monomer is colored as in
Figure 3b: N sheet green, helical domain
cyan, C sheet red, A sheet dark blue, disulfide
bonds yellow, lipids (L1 and L2) orange, and
the phosphate of L1 purple. The 38 energy-
minimized DPPC molecules are drawn in pink
except for their phosphate atoms which were
drawn as purple spheres. A representation of
biliverdin (pink) was placed in the inner lipid
region of the cavity. The biliverdin marks the
portion of the cavity assigned to neutral lipids.
(The figure was prepared using the program
SETOR [53].)
only on the N-terminal homology of lipovitellin with apoB
would not be reliable. Nonetheless, because the homolo-
gous region in the three proteins is a relatively compact
globular unit, this segment could be the portion that
serves as the framework for domains which are more
directly bound to aggregated lipid. Expression of only the
N-terminal 583 amino acids of apoB (the N sheet and
helical domain of lipovitellin), yields a soluble protein
which cannot bind enough lipid to form a lipoprotein [30].
One other major functional difference in these three pro-
teins is related to the nature of the lipid components.
Phospholipid is the principal component in lipovitellin,
while triglycerides and other neutral lipids make up the
majority of the lipid in LDL and VLDL (apoB). In the
crystal structure of lipovitellin, headgroups of the phos-
pholipids provide the hypothetical interface between the
cavity and the aqueous environment. The greater predom-
inance of triglycerides in MTP and apoB suggests that the
lipid cavity in these two proteins must have significantly
smaller aqueous interfaces relative to total cavity volume
than is found in crystalline lipovitellin.
Structure and function of lipovitellin
The lack of direct information on the positioning of bound
lipid in the crystal structure of lipovitellin makes it diffi-
cult to speculate on the most obvious question of function.
By what mechanism are the lipid components loaded
into the precursor structure? This question is further com-
plicated by the fact that the loading process and subse-
quent secretion occurs in the precursor, vitellogenin. The
mature lipovitellin form, for which the crystal structure is
known, is missing significant portions (678 amino acids) of
the polypeptide chain that must be present during the
lipid assembly.
One can more easily speculate about the removal of the
lipid portion. In this case, it is known that the presence of
the bound lipid is essential for the stability of the prote-
olytically processed lipovitellin. Once delipidated, some of
the polypeptide chains are insoluble and it is unlikely that
the removal of lipid can be reversed [31]. Recall that the
lipid-binding cavity is formed principally by the A sheet.
Formed primarily from two separate peptide chains, the
A sheet’s overall structure is dictated by the presence of
lipid in the cavity.
In the precursor vitellogenin dimer, the apoprotein is a
single polypeptide chain. It is likely that the precursor also
binds the two molecules of lipid, L1 and L2, mentioned
above. This process may mark the first step in the assem-
bly process. Although it is unknown whether these two
sites affect the conformation of the protein, the binding
sites are near the ball-and-socket site. This location is
where conformational changes probably occur as an
increasing amount of lipid is added to the apoprotein. 
The lipid domain of lamprey lipovitellin is known to
contain both phospholipid and a smaller amount of neutral
lipid. The crystal structure of the mature protein suggests
one sterically reasonable form of phospholipid organiza-
tion. In the model tested, the outermost segment would
contain the phospholipid organized in a monolayer form.
As noted above, the presence of a phospholipid monolayer
added to the crystal structure leaves an unoccupied inner
cavity to serve as the site for the neutral lipid.
In view of the protein framework of lipovitellin, a reason-
able assembly model is that lipid loading occurs cotransla-
tionally and before the presence of the fully folded poly-
peptide chain as visualized in the crystal structure reported
here. Simultaneous addition of neutral and phospholipid
during protein folding eliminates the need for conforma-
tional changes which would be required to give access to
the inner or neutral lipid segment of the cavity. If the
current positioning of the phospholipid is accepted, its
loading could involve a single-step removal from the inner
leaflet of any nearby bilayer membrane. 
Summary
The placement of the amino acid sequence into the elec-
tron-density map agrees with all aspects of the available
X-ray and sequence data. The interpretation of the elec-
tron-density map was very difficult for several reasons. One
of them was the fact that no chemical sequence was easily
obtainable from the C-terminal end of each chain. Derived
endings based on SDS–PAGE molecular weights turned
out to be unsatisfactory. In addition, many polypeptide seg-
ments were disordered and weak electron-density, particu-
larly at surface turns, made tracing the chains difficult. In
spite of these difficulties, most of the secondary structure
was plainly visible and the X-ray coordinates refined to a
reasonable agreement with the diffraction data. The X-ray
crystallographic studies could be carried one step further.
The crystals, which are identical to those found in situ [32],
can be studied by very low temperature data collection
methods. This might reduce some of the observed disorder,
permit visualization of additional lipid molecules, and
extend the resolution of the X-ray study.
Biological implications
The secretion and uptake of soluble lipoprotein mol-
ecules represents the major pathway for the relocation of
large quantities of lipid in higher organisms. Mechanisms
for the assembly of these complex molecules are difficult
to envision because of a lack of information on their mol-
ecular structures. Vitellogenin’s proteolytically
processed subform, lipovitellin, is a relatively homo-
geneous stable lipid–protein complex that has been crys-
tallized and analyzed by X-ray crystallography. 
Because of its size and abundance during reproductive
cycles, vitellogenin mRNA was one of the first mRNAs
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to be identified. Like apolipoprotein B-100, vitellogenin
is synthesized in the liver, secreted into the serum, and
imported into target tissues (e.g., oocytes) through
receptor-mediated endocytosis with receptors that are
homologous to low density lipoprotein (LDL) recep-
tors. Subsequent to the receptor-mediated uptake, the
lipid–protein complex vitellogenin is proteolytically
processed into several polypeptide chains which form
lipovitellin and phosvitin. In its final deposited form,
lipovitellin contains about 16% w/w lipid —mostly phos-
pholipid with some neutral lipid. The proteolytic pro-
cessing does not appear to alter lipid binding, and the
X-ray model of lipovitellin is probably closely related to
the molecular structure of vitellogenin.
The molecular structure derived from X-ray crystallo-
graphic analysis provides insights into the lipid stabiliza-
tion and guidelines for potential assembly mechanisms.
The large cavity or indentation that appears in the
refined X-ray model contains the tightly bound lipid. The
location of two other unique lipid sites suggest that they
may have a role in the nucleation of lipid uptake during
assembly of the complex. Because the cavity has a
surface which is exposed to the aqueous environment,
the alignment of phospholipid headgroups in the hypo-
thetical monolayer could provide a required interface to
the milieu.
A segment of the polypeptide chain containing a large
number of phosphorylated serines was missing in the
X-ray studies, but is known to exist from NMR studies.
The lack of electron-density for this segment indicates it
is in a disordered state relative to the rest of the lipo-
protein. On the basis of N-terminal analyses and molecu-
lar weight studies, several other small segments of
lipovitellin are also missing in the X-ray crystallographic
model. As they remain with the complex throughout the
purification and crystallization procedures, they also
must be an integral part of the lipid–protein complex.
The lack of electron-density and the assumed fluidity of
these segments suggests that they may be interacting
directly with the lipid-containing domain.
Comparison of the amino acid sequence and exon–intron
boundaries of lipovitellin with those of two other lipopro-
teins — microsomal triglyceride transfer protein (MTP)
and apolipoprotein B-100 (apoB) —reveals regions of
homology. The crystal structure described here therefore
offers a template for the structure of MTP and a segment
of apoB. These three proteins exhibit dramatically differ-
ent levels of lipid binding and explanation for this may lie
outside of the purported homology regions. One hypothe-
sis would be that the fourth domain of lipovitellin, the
A sheet, is responsible for the size of the lipid-binding
cavity. The larger the potential A sheet of the molecule
the larger the total amount of lipid which can associate
with the protein. MTP has only about 200 amino acids to
form a putative A sheet, the lipovitellin A sheet comprises
over 400 amino acids, and apoB has several thousand
amino acids to form a putative A sheet. This increase of
residues to the C terminus of the homology region corre-
lates with the increased number of lipid molecules bound
by each protein.
Materials and methods
X-ray data
Crystalline lamprey lipovitellin belongs to the monoclinic class, C2 with
cell dimensions of a = 192.9, b = 87.1, c = 91.0 Å and β = 100.92°.
The X-ray data was collected on the Xuong-Hamlin multiwire detector
and is described in an earlier report by Raag et al. It contains reflec-
tions to 2.8 Å with an Rsym of 6.1%. Heavy-atom phasing statistics from
four derivatives lead to an overall figure of merit of 0.49. Although
lipovitellin is a dimer, the molecular symmetry is coincident with a crys-
tallographic twofold rotation axis.
Sequence assignment
The N-terminal sequence and molecular weight assignment for two of
the polypeptide chains were taken from earlier publications [1,4].
According to the model derived from the X-ray data, LV1n has a mol-
ecular weight of about 75 kDa, a difference of nearly 8 kDa from the
molecular weight inferred from SDS–PAGE studies. An independent
measure of molecular weight was determined from the amino acid
composition. Protein chains were separated from each other using
preparative SDS–PAGE and gel filtration under denaturing conditions.
Approximately 10 µg of each isolated chain was submitted for amino
acid analysis on a Beckman 6300. A comparison of a histogram of the
amino acid composition and the predicted cDNA sequence suggests a
molecular weight of 71.5 kDa for LV1n. Similar comparisons for LV1c
and LV2 were within 1 kDa of the SDS–PAGE results.
The identification of pyroglutamate at Gln17 as the blocking group at
the N-terminal end of LV1n was based on the following arguments.
First, two other vertebrate LV1 chains which are not blocked, toad and
a killifish, have an N-terminal glutamate or asparagine that is homolo-
gous to Gln17. Second, there is no detectable electron density before
Gln17. Third, the electron density on an omit map at Gln17 is closely fit
by pyroglutamate. Fourth, pyroglutamate is a commonly modified form
of an N-terminal glutamine [33]. Fifth, Gln17 in vitellogenin marks the
most probable beginning of the LV1n chain of lipovitellin as determined
by a neural networks program developed by Nielsen et al. [15].
X-ray refinement
The initial map used for building the model was based on the previous
multiple isomorphic replacement model [2], and a new round of solvent
flattening [34]. A computer program was developed to aid in assigning
residues to the model using an eight-point scale to characterize side-
chain density. The underlying method compared a region of sidechain
density of defined character to an input amino acid sequence and
selected the sequences with the best match. It also permitted the
linking together of several small segments with variable gaps.
Using this methodology, most of the amino acid sequence of the helical
domain (Thr297–Met611) and a large portion of the A sheet (Gly791
to Leu945) were placed in the electron-density map. For this sequence
assignment, the model building program MAID [35] was used for visu-
alization, and its real-space molecular dynamics options were used to
improve portions of the fit of the backbone to the map. Where the
sequence assignment could be made, sidechains were built into the
density using the rotamer database available in O [36], while the rest of
the model was refit with polyserine. An initial model consisting of 470
residues with assigned sidechains and 418 polyserines was then
refined (Rfree = 0.45 and R = 0.31) in X-PLOR [37,38]. The standard
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simulated annealing protocol and the geometry library of Engh and
Huber [39] were used with X-ray data from 2.8–8.0 Å [40]. The Rfree
dataset was approximately 3% of the overall X-ray data [38]. 
Using the phases obtained after density modification [3], the heavy-
atom parameters were re-refined for data between 2.8 and 20 Å using
MLPHARE [41] in the CCP4 package [42,43]. This map was then sub-
jected to density modification using the program DM (CCP4) [43,44]
including solvent flattening with 51% of the total unit-cell volume esti-
mated as solvent, histogram matching and iterative skeletonization to
obtain a map from 2.8–46 Å. Model phases were calculated using
SFALL (CCP4) and combined with DM phases using SIGMAA (CCP4)
for phases from 2.8–5.0 Å [43,45]. Electron-density maps were calcu-
lated using DM/model phases in the resolution range 2.8–5.0 Å and
DM phases in the range of 5.0–46 Å. Starting with this map, iterative
cycles of model building, restrained positional refinement, and phase
recombination were performed.
After several such cycles, a model was obtained with 1070 residues
on 10 chains. All further cycles with X-PLOR were done with a bulk
solvent correction applied to the model structure factors using the
values fsolvent = 0.33e/Å3 and Bsolvent = 55Å2. Rounds of restrained
positional energy refinement and individual B-factor refinement for all
reflections in the resolution range of 46–2.8 Å with no sigma cutoff
were followed by model rebuilding into Sim-weighted 2|Fo| – |Fc| and
|Fo| – |Fc| maps. This led to the final structure with sequence
assigned to 1129 residues on five chain fragments. Disulfide bonds
were restrained after at least one cycle of refinement as free –SH
groups. Lipid molecules were included in the structure if they appeared
in Sim-weighted |Fo| – |Fc| map at 3σ and 2|Fo| – |Fc| map at 1σ. A
diundecanoyl phosphatidylcholine was used as a template for L1, a
palmitoyl-hexanoyl-phosphatidylcholine. The tridecane (C13) was built
from a subset of stearic acid (PDB; 1lif). Both lipid molecules were
positioned into |Fo| — |Fc| density at a 1σ cutoff using torsion angle
manipulations. Parameter and topology files for use in X-PLOR were
generated with XPLO2D [46]. The 59 water molecules were built
into 4σ |Fo| — |Fc| peaks if there was at least one nearby hydrogen-
bond donor or acceptor. The final Rfree = 0.255 for all reflections
2.8–50.0 Å with no sigma cutoff. A final cycle of positional and tem-
perature factor refinement was done on the model using all data includ-
ing the Rfree reflections, and the final R = 0.194. 
The mean B factors for LV and its ligands are listed in Table 1. The root
mean square deviations (rmsd) from ideality in bond lengths, angles and
improper angles are 0.005 Å, 1.38° and 1.02°, respectively. The model
has good stereochemistry, with only seven outliers in a Ramachandran
plot (PROCHECK) [47]. Besides possessing good through-space con-
tacts between the various fragments, correct assignment of protein
sidechains was verified with the ERRAT [21] and Profile [48] programs.
The three strongest (CH3)HgCl heavy-atom sites were all very close to
three of the four free sulfhydryls present in the model. 
Building the phospholipid bilayer in the lipid cavity
The DPPC coordinates were generated by using BIOSYM [49] to add
five carbon atoms to each chain of a diundecanoyl phosphatidylcholine
(PDB, 1lpa). The monolayer shown in Figure 7 was constructed by
manually positioning the phosphatidylcholine molecules in the mouth of
the cavity, being careful to place phosphate groups close to the posi-
tively charged sidechains that are present at the outer ring of the cavity.
A round of conjugate gradient energy minimization was then carried out
using X-PLOR with fixed model protein coordinates and with the elec-
trostatic terms turned off. This was followed by minor lipid relocation
and further refinement.
Other methods and computer programs
Secondary structure assignments were done using the protocol of
Kabsch and Sander [50] as implemented in Promotif [17]. The interheli-
cal angles listed were calculated by Promotif. Solvent-accessible calcula-
tions were done using GRASP with a 1.4 Å solvent probe radius [51]. 
We refer frequently to homologous amino acid sequences in the vitello-
genin family. An alignment of the amino acid sequences of seven differ-
ent species has been made, including the amino acid sequences of
vitellogenin from toad (Y00354, EMBL), chicken (M18060, GenBank),
sturgeon (U00455, GenBank), trout (X92804, EMBL), lamprey (M88749,
GenBank) and two sequences from killifish (U70826 and U07055,
GenBank). The alignment covers approximately 1900 residues and is
available from the authors upon request. 
Accession numbers
Coordinates for the refined model and structure factors have been
deposited in the Protein Data Bank, Brookhaven, with accession code
1LLV.
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